Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients
Status:
Recruiting
Trial end date:
2022-10-09
Target enrollment:
Participant gender:
Summary
Phase III, prospective, interventional, multicentric, comparative, randomized, open study
with 2 parallel arms, evaluating the efficacy of Cicaderma ointment vs standard management of
each site in preventing the onset of grade > 2 radiodermatitis according to the National
Cancer Institute - Common Terminology Criteria for Adverse Events-Version (NCI-CTCAE-V5)